Inhibition of cell-cycle progression in HeLa cells by HY52, a novel cyclin-dependent kinase inhibitor isolated from Bauhinia forficata.
In the course of screening for a novel inhibitor of cyclin-dependent kinase (CDK), HY52 (C17H30O2N2; molecular weight 294) was isolated from the leaves of Pata de Vaca (Bauhinia forficata). The growth of HeLa cells was inhibited in a dose-dependent manner when treated with 0.07 to 0.41 mM of HY52 for 24 h (IC50:0.11 mM). Furthermore, HY52 showed the selective inhibitory activity on CDC2 kinase purified using immunoprecipitation with an IC 50 value of 0.45 mM. A flow cytometric analysis of the HeLa cells treated with HY52 revealed an appreciable cell-cycle arrest in the G1 phase. Moreover, a TUNEL assay exhibited the apoptotic induction of HeLa cells treated with HY52. To obtain further information on the cell-cycle arrest induced by HY52, the expression of certain cell-cycle-associated proteins was examined using a Western blot analysis. The results revealed that HY52 was found to inhibit the proliferation of HeLa cells through inducing a G1-phase arrest by inhibiting pRb phosphorylation via an up-regulation of p21WAF1/CIP1 and p27KIP1, and G2/M-phase arrest by down-regulation of CDC2, cyclin A, and cyclin B1.
Department of Medical Genetics, College of Medicine, Hanyang University, Seoul 133-791, Korea.
Haeyoung
H
Lim
Min Kyoung
MK
Kim
Yoongho
Y
Lim
Youl-Hee
YH
Cho
Chul-Hoon
CH
Lee
D000972:Antineoplastic Agents, Phytogenic / Q000494:pharmacology*; D017209:Apoptosis / Q000187:drug effects; D036481:Bauhinia / Q000737:chemistry*; D016203:CDC2 Protein Kinase / Q000037:antagonists & inhibitors; D049109:Cell Proliferation / Q000187:drug effects; D018844:Cyclin-Dependent Kinases / Q000037:antagonists & inhibitors*; D003510:Cyclohexanes / Q000494:pharmacology*; D006367:HeLa Cells; D006801:Humans; D006834:Hydrazines / Q000494:pharmacology*; D010766:Phosphorylation; D047428:Protein Kinase Inhibitors / Q000737:chemistry / Q000494:pharmacology*; D016160:Retinoblastoma Protein / Q000378:metabolism
D000972:Antineoplastic Agents, Phytogenic; D003510:Cyclohexanes; C509843:HY52 compound; D006834:Hydrazines; D047428:Protein Kinase Inhibitors; D016160:Retinoblastoma Protein; D016203:CDC2 Protein Kinase; D018844:Cyclin-Dependent Kinases